市場調査レポート

商品コード

1619108

医薬品市場規模、シェア、成長分析、分子別、製品別、タイプ別、疾患別、投与法別、処方別、年齢別、最終用途別、地域別 - 産業予測、2024～2031年

Pharmaceuticals Market Size, Share, Growth Analysis, By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Disease, By Administration, By Formulation, By Age, By End Use, By Region - Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

医薬品の世界市場規模は、2022年に2,098億5,000万米ドルと評価され、2023年の2,224億4,000万米ドルから2031年には3,545億4,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは6.0％で成長する見通しです。

医薬品は、医療目的で処方される薬剤含有製品と定義され、健康とウェルネスに対する消費者の意識の高まりによって需要が急増しています。この動向はCOVID-19パンデミックの際に加速し、ワクチン開発を担当する製薬会社は経済不安の中で生き延びただけでなく繁栄し、このセクターの回復力を浮き彫りにしました。個人が健康を優先するようになり、医薬品市場は継続的に成長する態勢が整っています。ヘルスケアソリューションへの継続的な取り組みは、社会における医薬品の重要な役割を強調し、公衆衛生のニーズが持続する限り、市場の持続的な拡大を保証するものです。イノベーションとアクセシビリティに重点を置くことで、医薬品業界は将来的に消費者の進化する需要に対応できる体制を整えています。

市場概要
心血管疾患
がん
糖尿病
感染症
神経疾患
呼吸器疾患
自己免疫疾患
精神疾患
胃腸障害
女性の健康疾患
遺伝性疾患および稀少遺伝性疾患
皮膚疾患
肥満
腎臓疾患
肝臓の病気
血液疾患
目の状態
不妊症
内分泌疾患
アレルギー
その他

医薬品市場規模：投与法別およびCAGR（2024～2031年）

市場概要
経口
局所
非経口
- 静脈内
- 筋肉内
吸入
その他

医薬品市場規模：処方別およびCAGR（2024～2031年）

市場概要
タブレット
カプセル
注射
スプレー
サスペンション
粉末
その他の処方

医薬品市場規模：年齢別およびCAGR（2024～2031年）

市場概要
子どもと青少年
大人
高齢者

医薬品市場規模：最終用途別およびCAGR（2024～2031年）

市場概要
病院
クリニック
その他

医薬品市場規模およびCAGR（2024～2031年）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021～2023年）

主要企業プロファイル

Pfizer（USA）
Johnson & Johnson（USA）
Roche（Switzerland）
Novartis（Switzerland）
Merck & Co.（USA）
AbbVie（USA）
Bristol Myers Squibb（USA）
Eli Lilly and Company（USA）
Bayer AG（Germany）
Sanofi（France）
AstraZeneca（UK）
Amgen（USA）
Takeda Pharmaceutical Company Limited（Japan）
Teva Pharmaceutical Industries Ltd.（Israel）
Merck KGaA（Germany）
Vertex Pharmaceuticals Incorporated（USA）
Biogen（USA）
Regeneron Pharmaceuticals, Inc.（USA）
Alexion Pharmaceuticals, Inc.（USA）
Astellas Pharma Inc.（Japan）

結論と推奨事項

Product Code: SQMIG35I2061

Global Pharmaceuticals Market size was valued at USD 209.85 billion in 2022 and is poised to grow from USD 222.44 billion in 2023 to USD 354.54 billion by 2031, growing at a CAGR of 6.0% during the forecast period (2024-2031).

Pharmaceuticals, defined as drug-containing products formulated for medical purposes, are witnessing a surge in demand, driven by increasing consumer awareness about health and wellness. This trend accelerated during the COVID-19 pandemic, where pharmaceutical companies responsible for vaccine development not only survived but thrived amidst economic instability, highlighting the sector's resilience. As individuals prioritize their health, the pharmaceutical market is poised for continued growth. The ongoing commitment to healthcare solutions underscores the essential role of pharmaceuticals in society, ensuring sustained market expansion as long as public health needs persist. With a focus on innovation and accessibility, the industry is well-positioned to meet the evolving demands of consumers in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceuticals Market Segmental Analysis

Global Pharmaceuticals Market is segmented by molecule, product, type, disease, administration, formulation, age, end use and region. Based on molecule, the market is segmented into biologics & biosimilars (large molecules) and conventional drugs (small molecules). Based on product, the market is segmented into branded and generic. Based on type, the market is segmented into prescription and OTC. Based on disease, the market is segmented into cardiovascular diseases, cancer, diabetes, infectious diseases, neurological disorders, respiratory diseases, autoimmune diseases, mental health disorders, gastrointestinal disorders, women's health diseases, genetic and rare genetic diseases, dermatological conditions, obesity, renal diseases, liver conditions, hematological disorders, eye conditions, infertility conditions, endocrine disorders, allergies and others. Based on administration, the market is segmented into oral, topical, parenteral, inhalations and other. Based on formulation, the market is segmented into tablets, capsules, injectable, sprays, suspensions, powders and other formulations. Based on age, the market is segmented into children & adolescents, adults and geriatric. Based on end use, the market is segmented into hospitals, clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceuticals Market

One of the key drivers of the Global Pharmaceuticals market is the rising aging population. Recent data from the Bureau of Census highlights a growth in the demographic of individuals aged 65 and older, increasing from 8% in 2015 to 9% in 2021. This demographic shift results from improved living standards and an expanding global population, significantly altering the population structure in many nations. The United Nations projects a staggering 56% rise in individuals aged 60 and above from 2015 to 2030. As people live longer, age-related health issues are becoming more prevalent, putting enormous pressure on healthcare systems worldwide. This scenario creates a critical need for innovative pharmaceutical solutions, as advancements in nanotechnology and artificial intelligence offer promising avenues to develop new treatments. Consequently, the growing patient base directly fuels the demand for medical interventions, driving substantial growth in the pharmaceuticals market.

Restraints in the Global Pharmaceuticals Market

The global pharmaceuticals market faces significant restraints stemming from a shortage of skilled labor and the volatility of raw material costs. The development of new drugs necessitates specialized skill sets that are currently available only in select research organizations, leading to an inadequate workforce. Additionally, fluctuating raw material prices hinder market expansion, creating further challenges for pharmaceutical companies. Compounding these issues is a pronounced talent gap, as the skills possessed by the current workforce do not adequately align with the advanced requirements of biopharma production. Companies struggle to find expertise in critical areas like automation, computer science, and process modeling, hindering innovation and progress within the industry.

Market Trends of the Global Pharmaceuticals Market

The Global Pharmaceuticals market is experiencing a significant trend toward restructuring and recovery post-COVID-19, as companies adapt to the new normal. As the demand for innovative therapies surges, firms are pivoting their business models to enhance resilience against future disruptions. The pandemic catalyzed a shift to digital health solutions and telemedicine, prompting pharmaceutical companies to invest in technology and streamline operations. There is also an increased focus on supply chain diversification and sustainability practices. This evolving landscape presents opportunities for growth and collaboration, positioning the pharmaceutical sector for a robust rebound and long-term evolution in healthcare delivery and access.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Pharmaceuticals Market Size by Molecule & CAGR (2024-2031)

Market Overview
Biologics & Biosimilars (Large Molecules)
Conventional Drugs (Small Molecules)

Global Pharmaceuticals Market Size by Product & CAGR (2024-2031)

Market Overview
Branded
Generic

Global Pharmaceuticals Market Size by Type & CAGR (2024-2031)

Market Overview
Prescription
OTC

Global Pharmaceuticals Market Size by Disease & CAGR (2024-2031)

Market Overview
Cardiovascular Diseases
Cancer
Diabetes
Infectious Diseases
Neurological Disorders
Respiratory Diseases
Autoimmune Diseases
Mental Health Disorders
Gastrointestinal Disorders
Women'S Health Diseases
Genetic and Rare Genetic Diseases
Dermatological Conditions
Obesity
Renal Diseases
Liver Conditions
Hematological Disorders
Eye Conditions
Infertility Conditions
Endocrine Disorders
Allergies
Others

Global Pharmaceuticals Market Size by Administration & CAGR (2024-2031)

Market Overview
Oral
Topical
Parenteral
- Intravenous
- Intramuscular
Inhalations
Other

Global Pharmaceuticals Market Size by Formulation & CAGR (2024-2031)

Market Overview
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Other Formulations

Global Pharmaceuticals Market Size by Age & CAGR (2024-2031)

Market Overview
Children & Adolescents
Adults
Geriatric

Global Pharmaceuticals Market Size by End Use & CAGR (2024-2031)

Market Overview
Hospitals
Clinics
Others

Global Pharmaceuticals Market Size & CAGR (2024-2031)

North America (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
- USA
- Canada
Europe (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Pfizer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regeneron Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alexion Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments